| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xoma Royalty Corp (XOMA) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. XOMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $55.41M | - | |
| CEO | 102.0K | $4.27M | - | |
| CFO | 30.1K | $1.26M | - | |
| CFO | 30.0K | $1.26M | - | |
| Dir | 23.8K | $998.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2015 | Baker Bros. Advisors LP59 | Former 10% Owner | Sell | 11,000,000 | $1.09 | $12,017,500.00 | -74.8% | |
| Jul 15, 2015 | Varian John | CEO | Sale+OE | 10,000 | $4.49 | $44,869.00 | -1.8% | |
| Jul 15, 2015 | Rubin Paul D | Sr. VP Clinical Dev. &CMO | Sale+OE | 5,000 | $4.60 | $22,992.00 | -3.9% | |
| Jul 10, 2015 | Rubin Paul D | Sr. VP Clinical Dev. &CMO | Sale+OE | 33,400 | $4.55 | $152,004.80 | -12.0% | |
| Jun 15, 2015 | Varian John | CEO | Sale+OE | 10,000 | $3.64 | $36,362.00 | -1.8% | |
| May 28, 2015 | Rubin Paul D | Sr. VP Clinical Dev. &CMO | Sale+OE | 1,788 | $3.60 | $6,436.80 | -1.4% | |
| May 15, 2015 | Varian John | CEO | Sale+OE | 10,000 | $3.34 | $33,400.00 | -1.8% | |
| Apr 15, 2015 | Varian John | CEO | Sale+OE | 10,000 | $3.86 | $38,606.00 | -1.8% | |
| Mar 23, 2015 | Rubin Paul D | Sr. VP Clinical Dev. &CMO | Sell | 32,742 | $3.94 | $128,879.06 | -21.5% | |
| Mar 16, 2015 | Varian John | CEO | Sale+OE | 10,000 | $3.72 | $37,223.00 | -1.8% |